10 assets in Insomnia

Therapeutic assets addressing Insomnia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lemborexant Insomnia	YangPan	P4	BBB (72)
Suvorexant Insomnia	Mayo Clinic	P4	BBB (72)
Daridorexant Insomnia	Institut d'Investigació Biomèdica de Bellvitge	P4	BB (65)
Melatonin Insomnia	Odense University Hospital	P3	BB (65)
Zopiclone Insomnia	Salem Anaesthesia Pain Clinic	Early P1	CC (47)
Propofol Insomnia	Nyree Penn	P1	CC (43)
Jnj-54135419 Insomnia	Nanjing First Hospital, Nanjing Medical University	N/A	D (30)
Pregabalin Insomnia	Helsinki University Central Hospital	N/A	D (30)